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New structure found in plain sight
 
ike explorers spotting an uncharted island on the horizon, 
Imanishi et al. (page 373) have identified a previously
unknown cellular structure that could be an entirely new organelle. 
The structure, located in cells of the retinal pigment epithelium, 
appears to be an essential waypoint in the retinoid cycle—the series 
of chemical reactions that regenerates 11-
 
cis
 
-retinal, the chromophore 
for rhodopsin, after light converts it to all-
 
trans
 
-retinal.
Isolated retinas do not survive long outside of the eye, complicating 
studies of retinal biology. The authors circumvented this problem 
L
Storage sites for retinyl esters called retinosomes (red) do not 
colocalize with organelles such as the Golgi (blue).
 
Krox-20 conducts the Schwann song
 
hen Schwann cells begin to 
myelinate large-diameter axons, 
they stop dividing, become resistant 
to apoptosis, and start producing 
myelin proteins. How are all of these 
changes coordinated? On page 385, 
Parkinson et al. identify several new 
signaling interactions in Schwann 
cells, and show that the transcription 
factor Krox-20 is a master regulator 
of myelination.
The authors found that Krox-20 
expression makes Schwann cells 
resistant to the mitogen NRG-1 and 
the apoptosis-inducing action of TGF-
 
 
 
. 
Rather than specifically targeting these 
signaling molecules, Krox-20 appears 
to act through a general mechanism, 
suppressing the activity of the JNK/c-Jun 
pathway. The data show that JNK/c-Jun 
signaling is required for both prolifer-
W
 
by looking directly into the eyes of live mice with two-photon 
fluorescent microscopy. Retinol and retinyl esters show weak 
intrinsic fluorescence, producing high-resolution images of intact 
retinal cells and revealing a fence-like intracellular structure dubbed 
the retinyl ester storage particle, or retinosome. In wild-type mice 
exposed to light, retinyl ester levels in retinosomes rise, and then 
fall, consistent with the recycling of retinoid intermediates produced 
by light exposure.
Retinosomes are absent in mice lacking the enzyme LRAT, 
which produces retinyl esters. Mice lacking RPE65, which is 
required for processing retinyl esters, accumulate large quantities 
of the esters in overgrown retinosomes. Biochemical analysis shows 
that retinosomes also contain adipose differentiation–related 
protein (ADRP).
The new structure provides a context for understanding the 
retinoid cycle. By compartmentalizing a portion of the cycle, the 
retinosome can locally enrich intermediates in the cycle to drive 
energetically unfavorable reactions. Just as important, sequestering 
the retinyl esters can prevent toxic reaction intermediates from 
poisoning the cell.
The retinosome’s highly ordered structure suggests that it 
incorporates other proteins, and the authors are now trying 
to use ADRP as a hook to isolate pure retinosomes for further 
analysis. Since defects in the retinoid cycle underlie many forms 
of congenital blindness, the ability to observe retinosomes 
directly in intact eyes may also provide a powerful diagnostic 
tool in the clinic. 
 
 
 
ative and apoptotic responses in 
Schwann cells. Krox-20 expression 
increases the expression of the scaffold 
protein JIP-1, a known inhibitor of JNK 
activity, and also decreases the level 
of c-Jun protein in the cell, providing 
two possible ways to inhibit JNK/c-Jun 
signals.
Surprisingly, expression of Krox-20 
in cultured 3T3 fibroblasts, which are 
not related to Schwann cells, causes 
the fibroblasts to stop dividing, resist 
apoptosis, and express the myelin 
genes periaxin and P
 
0
 
. The ability to 
induce so many specialized responses 
in a different cell type indicates that 
Krox-20 is a master regulator.
By turning off a single pathway that 
is activated by both NRG-1 and TGF-
 
 
 
, 
Krox-20 can coordinate changes in 
both proliferative and apoptotic activi-
ties without affecting other processes 
activated by growth factors. Its position 
as a master regulator explains why 
mutations in Krox-20 often lead to 
severe hereditary myelination disorders. 
Parkinson et al. are now trying to deter-
mine whether Krox-20 acts directly or 
indirectly to reduce c-Jun levels and 
induce myelin gene expression.
 
 
 
 
Krox-20 makes fibroblasts 
turn on myelin genes.
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